Manufacturer of Voglibose at Factory Price CAS NO.83480-29-9

Min.Order Quantity:: 25 Kilogram

Purity:: 99%

Port:: Any port in China

Payment Terms:: L/C,D/P,T/T,

Add to Inquiry Cart

Product Details

Keywords

Voglibose
Basen
83480-29-9

Quick Details

ProName: Manufacturer of Voglibose at Factory P...
CasNo: 83480-29-9
Molecular Formula: C10H21NO7
Appearance: Colourless Crystalline Solid
Application: Pharmaceutical Material
DeliveryTime: Within 3 days after payment confirmed
PackAge: 25kg/fiber drum
Port: Any port in China
ProductionCapacity: 1,000 Metric Ton/Year
Purity: 99%
Transportation: By sea
LimitNum: 25 Kilogram
Related Substances: Voglibose
Residue on Ignition: 0.3Max
Heavy Metal: <10ppm
Valid Period: 2 years
Voglibose: 83480-29-9

Superiority

1. we are one of the domestic largest manufacturers of api;

2. we are always supplier of products with higher quality and at more competitive price;

3. we are supplier of safe and ecofriendly products ;

4. we provide stable supply and efficient service;

5. delivery in time;

6. cooperate with scientific research institutions to keep the leading position on the field of technology.

7. we can provide products to all customers all over the world.

Details

voglibose basic information

product name: voglibose
synonyms: voglibose;3,4-dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-c-(hydroxymethyl)-d-epiinositol;3,4-dideoxy-4-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-2-c-(hydroxymethyl)-d-epinositol;5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol;voglibose, 99+%;a 71100;ao 128;basen
cas: 83480-29-9
mf: c10h21no7
mw: 267.28
einecs:
product categories: miscellaneous;voglibose;all inhibitors;inhibitors;intermediates & fine chemicals;pharmaceuticals;carbohydrates & derivatives;diabetes research
mol file: 83480-29-9.mol

voglibose usage and synthesis

chemical properties colourless crystalline solid
usage an alpha-glucosidase inhibitor used as an antidiabetic
usage an α-glucosidase inhibitor used as an antidiabetic.
usage for the treatment of diabetes. it is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications.
biological activity orally active α -glucosidase inhibitor (ic 50 values are 3.9 and 6.4 nm at sucrase and maltase respectively). increases glucagon-like peptide 1 (glp-1) secretion and decreases food consumption in ob/ob mice, and reduces plasma concentrations of glucose, triglycerides and insulin in wistar fatty rats. exhibits antidiabetic and antiobesity activity in vivo .

Post a RFQ

Cas No.:

Product Name:

Quantity: